The future for Chinese tech companies will hinge on their ability to turn uncertainty into innovation – and opportunity.

Shen reported for The Baltimore Evening Sun in the late 1980s and then for 17 years was a staff writer for The Washington Post. An award-winning writer on The Post’s Metro staff, she covered Maryland ...

Recombinant antibodies such as nanobodies are progressively demonstrating to be a valid alternative to conventional monoclonal antibodies also for clinical applications. Furthermore, they do not ...

Introduction: Coronavirus disease 2019 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Influential variants and mutants of this virus continue to ...